Evaluate what you have learned about the leadership of your selected organization.

/in /by

Evaluate what you have learned about the leadership of your selected organization.
Then, as the consultant, use evidence to characterize the organizational leadership approach in place at the onset of the management or leadership issue.
• Provide your insights about how an evidence-based leadership approach might be similar to or different from the organizational leadership’s.
• Synthesize possible leadership changes that you would suggest the organization consider.
• Provide evidence that supports your recommendations.
In a paragraph describe positive and negative implications of the leadership changes
Chosen organization: Insys therapeutics
Adams, K. (2021). Former Insys Therapeutics CEO to pay $5M for alleged improper opioid marketing. Becker’s Hospital Review – Healthcare News. https://www.beckershospitalreview.com/opioids/former-insys-therapeutics-ceo-to-pay-5m-for-alleged-improper-opioid-marketing.html
US Food and Drug Administration (2020, April 6). Founder and former chairman of the board of Insys therapeutics. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/press-releases/founder-and-former-chairman-board-insys-therapeutics-sentenced-66-months-prison
Insys therapeutics INC. (n.d.). Retrieved February 08, 2021, from https://www.nytimes.com/topic/company/insys-therapeutics-inc
Garrison, J. (2020, January 24). John Kapoor, founder of Insys THERAPEUTICS, sentenced to 66 months in landmark Fentanyl bribery case. Retrieved February 08, 2021, from https://www.usatoday.com/story/news/nation/2020/01/23/insys-therapeutics-founder-john-kapoor-serve-66-months-prison-opioid-scheme/4552871002/
US Department of Justice (2019, June 5). Opioid manufacturer Insys therapeutics agrees to enter $225 million global resolution of criminal and civil investigations. https://www.justice.gov/opa/pr/opioid-manufacturer-insys-therapeutics-agrees-enter-225-million-global-resolution-criminal